ArticleMolecular pharmaceutics2013

A novel SERCA inhibitor demonstrates synergy with classic SERCA inhibitors and targets multidrug-resistant AML.

Nicholas P Bleeker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.